353 related articles for article (PubMed ID: 24843023)
1. Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1.
Jia X; Weber E; Tokarev A; Lewinski M; Rizk M; Suarez M; Guatelli J; Xiong Y
Elife; 2014 Apr; 3():e02362. PubMed ID: 24843023
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
3. Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism.
Lukhele S; Cohen ÉA
Retrovirology; 2017 Mar; 14(1):18. PubMed ID: 28288652
[TBL] [Abstract][Full Text] [Related]
4. Vpu binds directly to tetherin and displaces it from nascent virions.
McNatt MW; Zang T; Bieniasz PD
PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949
[TBL] [Abstract][Full Text] [Related]
5. Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly.
Lewinski MK; Jafari M; Zhang H; Opella SJ; Guatelli J
J Biol Chem; 2015 Apr; 290(17):10919-33. PubMed ID: 25759385
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
7. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.
Kueck T; Neil SJ
PLoS Pathog; 2012; 8(3):e1002609. PubMed ID: 22479182
[TBL] [Abstract][Full Text] [Related]
8. Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.
Kueck T; Foster TL; Weinelt J; Sumner JC; Pickering S; Neil SJ
PLoS Pathog; 2015 Aug; 11(8):e1005141. PubMed ID: 26317613
[TBL] [Abstract][Full Text] [Related]
9. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R; Neil SJ
J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
[TBL] [Abstract][Full Text] [Related]
10. Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
Rollason R; Dunstan K; Billcliff PG; Bishop P; Gleeson P; Wise H; Digard P; Banting G
PLoS One; 2013; 8(9):e75680. PubMed ID: 24086611
[TBL] [Abstract][Full Text] [Related]
11. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
Mitchell RS; Katsura C; Skasko MA; Fitzpatrick K; Lau D; Ruiz A; Stephens EB; Margottin-Goguet F; Benarous R; Guatelli JC
PLoS Pathog; 2009 May; 5(5):e1000450. PubMed ID: 19478868
[TBL] [Abstract][Full Text] [Related]
12. The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.
Waheed AA; Swiderski M; Khan A; Gitzen A; Majadly A; Freed EO
J Biol Chem; 2020 May; 295(21):7327-7340. PubMed ID: 32291285
[TBL] [Abstract][Full Text] [Related]
13. LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.
Madjo U; Leymarie O; Frémont S; Kuster A; Nehlich M; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
Cell Rep; 2016 Nov; 17(9):2221-2233. PubMed ID: 27880899
[TBL] [Abstract][Full Text] [Related]
14. Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.
Roy N; Pacini G; Berlioz-Torrent C; Janvier K
J Cell Sci; 2017 May; 130(9):1596-1611. PubMed ID: 28320822
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.
Dubé M; Paquay C; Roy BB; Bego MG; Mercier J; Cohen EA
Traffic; 2011 Dec; 12(12):1714-29. PubMed ID: 21902775
[TBL] [Abstract][Full Text] [Related]
16. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT
Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048
[TBL] [Abstract][Full Text] [Related]
17. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.
Dotson D; Woodruff EA; Villalta F; Dong X
J Biol Chem; 2016 Feb; 291(8):4236-46. PubMed ID: 26742839
[TBL] [Abstract][Full Text] [Related]
18. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin.
Janvier K; Roy N; Berlioz-Torrent C
Curr HIV Res; 2012 Jun; 10(4):315-20. PubMed ID: 22524180
[TBL] [Abstract][Full Text] [Related]
19. Phosphoserine acidic cluster motifs bind distinct basic regions on the μ subunits of clathrin adaptor protein complexes.
Singh R; Stoneham C; Lim C; Jia X; Guenaga J; Wyatt R; Wertheim JO; Xiong Y; Guatelli J
J Biol Chem; 2018 Oct; 293(40):15678-15690. PubMed ID: 30135209
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane interactions of HIV-1 Vpu and tetherin.
Guo F; Liang C
Curr HIV Res; 2012 Jun; 10(4):292-7. PubMed ID: 22524177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]